Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Go Take a Hike -- Safely

Before setting out on a hike, make sure you're prepared for the unexpected. The American Hiking Society outlines 10 things needed on every hike, starting with appropriate footwear. Trail shoes are fine for a short day hike that doesn't involve carrying a heavy pack or negotiating difficult terrain. But hiking boots, which offer more support, are a better...

Posted today in Medical

Depression Linked to Death of Many Heart Failure Patients

Depression significantly increases the risk of death in heart failure patients, a new study finds. Heart failure patients with moderate to severe depression had a five times higher risk of death than those with no or mild depression, researchers found. "We know that depression is common in heart failure and affects 20 to 40 percent of patients," said...

Posted 3 days ago in Clinical Trials

Ardelyx Presents Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C

Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo....

Posted yesterday in Medical

Health Highlights: May 22, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: FDA: Inadequate Testing, Cleaning at Jeni's Ice Cream Plant There was inadequate cleaning and testing at Jeni's Splendid Ice Creams plant in Columbus, Ohio before listeria was detected in some of its ice cream, a Food and Drug Administration investigation...

Posted yesterday in Medical

Health Tip: Exercise Boosts Heart Health

-- Exercise may be just what the doctor ordered to improve heart health. The National Heart Lung and Blood Institute says potential benefits of exercise include: Reducing blood pressure and triglycerides. Boosting "good" HDL cholesterol. Improving levels of blood sugar, thereby reducing the risk of type 2 diabetes. Cutting proteins responsible...

Posted 2 days ago in Medical

Too Few Younger, High-Risk Americans Get a Colonoscopy: Study

A majority of people with a family history of colon cancer are not getting screened for the disease early enough, a new study finds. Guidelines say colonoscopies should start at age 40 for people with a close relative who had colon cancer. However, only 38 percent of those people have a colonoscopy between ages 40 and 49, researchers report. "This...

Posted yesterday in Medical

Treating Gum Disease Might Help Prostate Symptoms: Study

Treating gum disease may help reduce symptoms of prostate inflammation, which can make urination difficult, a small study suggests. Previous research has shown a link between gum disease and prostate inflammation -- called prostatitis. The study included 27 men, age 21 and older, who had prostatitis and moderate to severe gum disease. The men underwent...

Posted 2 days ago in Medical

Health Highlights: May 21, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Climate Change a National Security Threat: Obama Climate change is a threat to national security, President Barack Obama says. On Wednesday, he told cadets at the U.S. Coast Guard Academy in New London, Connecticut that people who deny climate...

Posted 2 days ago in Medical

Researchers Report Progress in Making All Blood Types Universally Accepted

Scientists are closing in on a way to transform any type of donated blood into type O, the universal blood type that can safely be given to any patient. Researchers have created a special enzyme that can shear off the substances on red blood cells that are responsible for potentially fatal immune reactions if a patient receives the wrong type of blood,...

Posted 2 days ago in Medical

Weight Training's Benefits May Depend on Genetics

How well resistance exercises work may depend on a woman's genetic risk for obesity, new research suggests. Strength-building workouts seem to be most effective for those with a low genetic risk for a high body-mass index (BMI), the study found. BMI is a rough estimate of a person's body fat -- the higher the number, the more fat a person has. "This...

Read more news...

Recently added consumer and prescribing information: Kybella, Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web4)